Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France - Kabeshova, A; Ben Hariz, S; Tsakeu, E; Benamouzig, R; Launois, R (Therap Adv Gastroenterol, 2016)